From: Novel monitoring technique to minimise the risk for patients participating in pilot studies of investigational compounds
Number of patients observed
4
10
16
20
26
30
70% failure stopping threshold
3
7
12
14
19
21
LR stopping threshold
4 (100%)
5 (50%)
7 (44%)
8 (40%)
9 (35%)
10 (33%)